Cargando…
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation
Amyotrophic lateral sclerosis (ALS) is a devastating disease caused by degeneration of motor neurons. As with all major neurodegenerative disorders, development of disease-modifying therapies has proven challenging for multiple reasons. Nevertheless, ALS is one of the few neurodegenerative diseases...
Autores principales: | Mead, Richard J., Shan, Ning, Reiser, H. Joseph, Marshall, Fiona, Shaw, Pamela J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768794/ https://www.ncbi.nlm.nih.gov/pubmed/36543887 http://dx.doi.org/10.1038/s41573-022-00612-2 |
Ejemplares similares
-
Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis
por: Richardson, Peter J., et al.
Publicado: (2023) -
Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis
por: Ciervo, Yuri, et al.
Publicado: (2017) -
Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?
por: Webster, Christopher P., et al.
Publicado: (2017) -
Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis
por: Longinetti, Elisa, et al.
Publicado: (2017) -
Viral Delivery of Antioxidant Genes as a Therapeutic Strategy in Experimental Models of Amyotrophic Lateral Sclerosis
por: Nanou, Aikaterini, et al.
Publicado: (2013)